Bulk Pharmaceutical API Sources for SAXAGLIPTIN HYDROCHLORIDE

Bulk Pharmaceutical API Sources for SAXAGLIPTIN HYDROCHLORIDE

Vendor	Vendor Homepage	Vendor Sku	API Url
A2Z Chemical		AZB32139
AKos Consulting & Solutions		AKOS025290185
ChemShuttle		158516
LGC Standards		LGCFOR3377.00

Bulk Active Pharmaceutical Ingredient (API) Sources for Saxagliptin Hydrochloride

Last updated: February 20, 2026

Summary:
Saxagliptin hydrochloride is a DPP-4 inhibitor used for type 2 diabetes management. Its global API manufacturing is distributed across multiple regions, with leading suppliers including China, India, and the United States. Availability depends on regulatory approval, manufacturing capacity, and supply chain agreements. Major API producers are licensed by global pharmaceutical companies, with some operating as CDMOs (Contract Development and Manufacturing Organizations). Sourcing options include both branded API producers and generic suppliers.

Key API Manufacturing Regions and Major Suppliers

Region	Leading Companies	Notable Characteristics
China	Zhejiang Huahai Pharmac., Zhejiang Hisun Pharma, Jiangsu Hengrui Medicine	Largest manufacturing capacity; competitive pricing; widespread distribution
India	Sun Pharma, Divi's Laboratories, Aurobindo Pharma	High-quality standards; large export volumes; extensive regulatory compliance
United States	Teva Pharmaceuticals, Amneal Pharmaceuticals	Focus on innovation; stricter regulatory environment; FS (Formulation and Supply) options
Europe	Novartis, Sandoz (Novartis division)	Smaller market share; specialized manufacturing; higher prices

API Sources in Detail

China

• Zhejiang Huahai Pharmac.: One of the largest API producers globally, with a significant portfolio in cardiovascular and antidiabetic APIs. Regulatory audits have affected some Chinese suppliers, but they remain key players.
• Zhejiang Hisun Pharma: Manufactures saxagliptin API under strict regulatory standards, supplying both the domestic and international markets.
• Jiangsu Hengrui Medicine: Offers competitive pricing and has multiple manufacturing sites with GMP certification.

India

• Sun Pharma: Supplies saxagliptin hydrochloride API, leveraging extensive R&D and manufacturing facilities.
• Divi’s Laboratories: Known for high-quality APIs; major supplier to the global market, with a compliant regulatory track record.
• Aurobindo Pharma: Supplies at competitive prices; possesses multiple manufacturing plants with global GMP certification.

United States

• Teva Pharmaceuticals: Engages in API supply for branded and generic drugs, including saxagliptin hydrochloride, ensuring US-based manufacturing and supply chain security.
• Amneal Pharmaceuticals: Offers API manufacturing capacity and supplies to North American markets.

Europe

• Limited direct API manufacturing; mostly relies on imports or licensed production from Asian suppliers.

Regulatory and Quality Considerations

• API suppliers must comply with GMP standards per the FDA, EMA, and PMDA.
• Suppliers with ISO certifications and regular audits are preferred.
• Sourcing from True API manufacturers versus middlemen or brokers reduces risks, ensures traceability, and maintains quality.

Supply Chain Dynamics

• The supply chain for saxagliptin hydrochloride API hinges on regulatory approvals from end markets.
• Trade policies and tariffs influence pricing and sourcing options.
• The recent emphasis on local manufacturing in the US and Europe aims to reduce reliance on Asian exporters.

Conclusion

Major sourcing options for saxagliptin hydrochloride API are concentrated in China and India, with US-based suppliers providing domestic options for assurance of supply chain security. Enterprises must vet suppliers based on GMP compliance, capacity, regulatory track record, and pricing.

Key Takeaways

• Top global API suppliers for saxagliptin hydrochloride are in China and India.
• US and European sources are available but less prevalent.
• Regulatory compliance and GMP standards are critical for supplier selection.
• Supply chain considerations include tariffs, trade policies, and manufacturing capacity.
• Quality assurance involves selecting suppliers with verified certifications and audit histories.

FAQs

1. What factors determine the choice of API supplier for saxagliptin hydrochloride?
Regulatory compliance, manufacturing capacity, GMP certification, pricing, and supply chain stability.

2. Are there generic API sources available for saxagliptin hydrochloride?
Yes, primarily from Indian and Chinese generic API manufacturers.

3. How does regulatory approval affect API sourcing?
Suppliers must meet standards set by regulatory agencies such as the FDA and EMA, impacting market access and supply chain reliability.

4. What are the risks associated with sourcing from Chinese API manufacturers?
Potential regulatory audits, quality variability, and geopolitical trade restrictions.

5. Is US-based manufacturing a viable option for saxagliptin API?
Yes, but costs are generally higher; US suppliers offer supply chain security and compliance advantages.

References

1. Food and Drug Administration (FDA). (2022). GMP regulations for API manufacturing.
2. European Medicines Agency (EMA). (2021). API standards and regulatory requirements.
3. IQVIA. (2022). Global API manufacturing overview.
4. Pharma Business Insights. (2022). Global supply chain analysis for APIs.
5. World Health Organization (WHO). (2020). Guidelines on good manufacturing practices.